MedTrace Logo

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

NCT05001776 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2023-12-20

No results posted yet for this study

Summary

Рrospective single-centre randomized open-label study for comparison three modes of treatment for thrombosis of varicose great saphena vein - standard medical with fondaparinux sodium for 45 days, endovenous laser ablation close to the saphenofemoral junction with a 7-day course of anticoagulation and endovenous laser ablation close to the saphenofemoral junction without the use of anticoagulants.

Conditions

  • Superficial Vein Thrombosis
  • Endovenous Laser Ablation

Interventions

PROCEDURE

Endovenous laser ablation

Laser ablation of the great saphenous vein close to sapheno-femoral junction

DRUG

Fondaparinux Sodium

Fondaparinux sodium for 7 days or 45 days

Sponsors & Collaborators

  • National Medical Research Center for Therapy and Preventive Medicine

    lead OTHER_GOV

Principal Investigators

  • Igor S Yavelov, MD · National Medical Research Center for Therapy and Preventive Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05001776 on ClinicalTrials.gov